Heated lipiodol as an embolization agent for transhepatic arterial embolization in VX2 rabbit liver cancer model

European Journal of Radiology

Volumn 73, Issue 2, 2010, Pages 412-419

  Cao, Wei ^a   Wan, Yi ^b   Liang, Zhi Hui ^c   Duan, Yun You ^a   Liu, Xi ^a   Wang, Zhi Min ^a   Liu, Yi Yong ^a   Zhu, Jia ^a   Liu, Xiong Tao ^a   Zhang, Hong Xin ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

Author keywords

Heated lipiodol; Intervention procedure; Liver neoplasms; Model; Rabbits; Therapy

Indexed keywords

AFTER-TREATMENT; ARTERIAL EMBOLIZATION; ASPARTATE AMINOTRANSFERASE; CARCINOMA CELLS; CONTROL GROUPS; DOXORUBICIN; EMBOLIZATION AGENTS; HEPATIC ARTERY; INTERVENTION PROCEDURE; LIPIODOL; LIVER CANCERS; LIVER NEOPLASMS; NEW ZEALAND WHITE RABBIT; PHYSIOLOGICAL SALINE; RABBIT MODELS; STATISTICALLY SIGNIFICANT DIFFERENCE; THERAPEUTIC EFFECTS; TUMOR GROWTH; TUMOR VOLUMES; ULTRASONOGRAPH;

ANIMALS; BODY FLUIDS; LIVER; ONCOLOGY;

TUMORS;

ASPARTATE AMINOTRANSFERASE; DOXORUBICIN; IODINATED POPPYSEED OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOPSY; CONTROLLED STUDY; ECHOGRAPHY; EXPERIMENTAL RABBIT; HEPATIC ARTERY; LIVER CANCER; MALE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; HEMOSTATICS; HOT TEMPERATURE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; RABBITS; TREATMENT OUTCOME;

EID: 76349122659     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.11.001     Document Type: Article

References (43)

1. Tang Z., Zhou X., Lin Z., et al. Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis. Chin Med J (Engl) 112 10 (1999) 887-891
2. Tang Z.Y. Treatment of hepatocellular carcinoma. Digestion 59 5 (1998) 556-562
3. Yan F.H., Zhou K.R., Cheng J.M., et al. Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE. World J Gastroenterol 8 4 (2002) 658-662
4. Faivre J., Forman D., Esteve J., Obradovic M., and Sant M. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. Eur J Cancer 34 14 (1998) 2184-2190
5. El-Serag H.B., Mason A.C., and Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 33 1 (2001) 62-65
6. Vogl T.J., Trapp M., Schroeder H., et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 214 2 (2000) 349-357
7. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359 9319 (2002) 1734-1739
8. Achenbach T., Seifert J.K., Pitton M.B., Schunk K., and Junginger T. Chemoembolization for primary liver cancer. Eur J Surg Oncol 28 1 (2002) 37-41
9. Uchida H., Matsuo N., Sakaguchi H., Nagano N., Nishimine K., and Ohishi H. Segmental embolotherapy for hepatic cancer: keys to success. Cardiovasc Intervent Radiol 16 2 (1993) 67-71
10. Matsui O., Kadoya M., Yoshikawa J., et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188 1 (1993) 79-83
11. Poon R.T., Ngan H., Lo C.M., Liu C.L., Fan S.T., and Wong J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 73 2 (2000) 109-114
12. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 5 (2002) 1164-1171
13. Huang J., He X., Lin X., Zhang C., and Li J. Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma. Chin Med J (Engl) 113 5 (2000) 446-448
14. Murray T.G., Cicciarelli N., McCabe C.M., et al. In vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell line. Invest Ophthalmol Vis Sci 38 12 (1997) 2516-2522
15. Lee J.M., Lee Y.H., Kim Y.K., et al. Combined treatment of radiofrequency ablation and acetic acid injection: an in vivo feasibility study in rabbit liver. Eur Radiol 14 7 (2004) 1303-1310
16. Denys A.L., De Baere T., Kuoch V., et al. Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems. Eur Radiol 13 10 (2003) 2346-2352
17. Buscarini E., and Buscarini L. Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report. Eur Radiol 14 1 (2004) 31-37
18. Sturm J.W., Keese M.A., Bonninghoff R.G., Wustner M., and Post S. [Locally ablative therapies of hepatocellular carcinoma]. Onkologie 24 Suppl 5 (2001) 35-45
19. Guan Y.S., and Liu Y. Interventional treatments for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 5 4 (2006) 495-500
20. Honda N., Guo Q., Uchida H., Ohishi H., and Hiasa Y. Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy. Radiology 190 1 (1994) 53-57
21. Bjornaes I., and Rofstad E.K. Microvascular permeability to macromolecules in human melanoma xenografts assessed by contrast-enhanced MRI-intertumor and intratumor heterogeneity. Magn Reson Imaging 19 5 (2001) 723-730
22. Livraghi T., Goldberg S.N., Lazzaroni S., et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 214 3 (2000) 761-768
23. Livraghi T., Solbiati L., Meloni M.F., Gazelle G.S., Halpern E.F., and Goldberg S.N. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226 2 (2003) 441-451
24. Buscarini L., Buscarini E., Di Stasi M., Vallisa D., Quaretti P., and Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 11 6 (2001) 914-921
25. Livraghi T., Solbiati L., Meloni F., Ierace T., Goldberg S.N., and Gazelle G.S. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer 97 12 (2003) 3027-3035
26. Rossi S., Garbagnati F., Lencioni R., et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 217 1 (2000) 119-126
27. Yan K., Chen M.H., Yang W., et al. Radiofrequency ablation of hepatocellular carcinoma: Long-term outcome and prognostic factors. Eur J Radiol 67 2 (2008) 336-347
28. Doyon D., Mouzon A., Jourde A.M., Regensberg C., and Frileux C. [Hepatic, arterial embolization in patients with malignant liver tumours (author's transl)]. Ann Radiol (Paris) 17 6 (1974) 593-603
29. Llovet J.M., and Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 37 2 (2003) 429-442
30. Nakamura H., Hashimoto T., Oi H., et al. Treatment of hepatocellular carcinoma by segmental hepatic artery injection of adriamycin-in-oil emulsion with overflow to segmental portal veins. Acta Radiol 31 4 (1990) 347-349
31. Takayasu K., Shima Y., Muramatsu Y., et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 163 2 (1987) 345-351
32. Nakamura H., Hashimoto T., Oi H., and Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170 3 Pt 1 (1989) 783-786
33. Hamuro M., Nakamura K., Sakai Y., et al. New oily agents for targeting chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 22 2 (1999) 130-134
34. Zhao J.G., Feng G.S., Kong X.Q., Li X., Li M.H., and Cheng Y.S. Changes of tumor microcirculation after transcatheter arterial chemoembolization: first pass perfusion MR imaging and Chinese ink casting in a rabbit model. World J Gastroenterol 10 10 (2004) 1415-1420
35. Ko Y.H., Pedersen P.L., and Geschwind J.F. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett 173 1 (2001) 83-91
36. Geschwind J.F., Artemov D., Abraham S., et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol 11 10 (2000) 1245-1255
37. Ramirez L.H., Zhao Z., Rougier P., et al. Pharmacokinetics and antitumor effects of mitoxantrone after intratumoral or intraarterial hepatic administration in rabbits. Cancer Chemother Pharmacol 37 4 (1996) 371-376
38. Yeh C.N., Chen M.F., Lee W.C., and Jeng L.B. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 81 4 (2002) 195-202
39. Ercolani G., Grazi G.L., Ravaioli M., et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 237 4 (2003) 536-543
40. Konno T. Targeting chemotherapy for hepatoma: arterial administration of anticancer drugs dissolved in Lipiodol. Eur J Cancer 28 2-3 (1992) 403-409
41. Nesher E., Greenberg R., Avital S., Skornick Y., and Schneebaum S. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis. Isr Med Assoc J 9 11 (2007) 787-790
42. Muraoka A., Takeda S., Matsui M., et al. Experimental study of a novel thermotherapy for hepatocellular carcinoma using a magnesium ferrite complex powder that produces heat under a magnetic field. Hepatogastroenterology 51 60 (2004) 1662-1666
43. Feldman E.D., Wu P.C., Beresneva T., et al. Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion. J Gastrointest Surg 8 2 (2004) 200-207